Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/04/041594
CTRI/2022/04/041594
Completed
Phase 2

A RANDOMIZED COMPARATIVE CLINICAL TRIAL TO STUDY THE EFFECT OF SHATPUSHPA CHURNA, DHANYAK SHUNTHI PANIYA AND NIDANA PARIVARJAN IN MANDAGNI WITH SPECIAL REFERENCE TO SUBCLINICAL HYPOTHYROIDISM.

ATIONAL INSTITUTE OF AYURVEDA DEEMED TO BE UNIVERSITY JAIPUR0 sites41 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ATIONAL INSTITUTE OF AYURVEDA DEEMED TO BE UNIVERSITY JAIPUR
Enrollment
41
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
July 15, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ATIONAL INSTITUTE OF AYURVEDA DEEMED TO BE UNIVERSITY JAIPUR

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients between the age of 18\-60 years of either sex.
  • •2\.Patients with subclinical hypothyroidism with TSH levels ranging from 5\.5µIU/ml \- 20µIU/ml.
  • •3\. k/c/o Subclinical Hypothyroidism but still not taking Levothyroxine therapy.
  • •4\.Patients willing to take Ayurvedic medicine and sign the consent form.
  • •5\.Patients having symptoms of Mandagni.

Exclusion Criteria

  • •1\.TSH level above 20 µIU/ml.
  • •2\.Patients already under Levothyroxine therapy.
  • •3\.Patients suffering from congenital hypothyroidism, overt hypothyroidism, and secondary hypothyroidism.
  • •4\.Patients of hyperthyroidism, neoplasia, toxic goitre are excluded.
  • •5\.Patients who have undergone any type of thyroid surgery.
  • •6\.Patients suffering from systemic diseases like cardiac problems, diabetes, carcinomas etc.
  • •7\.Patients taking drugs known to alter thyroid hormone level (e.g., Amiodarone)
  • •8\.Patients who are pregnant or expecting pregnancy in next six months.
  • •9\.Recent hospitalization for major illness, to exclude with ESS (Euthyroid Sick Syndrome).

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
ROLE OF TRYUSHANADYA LAUHA AND LEKHANIYA MAHAKASHAYA IN STHAULAY (OBESITY) TO REDUCE WEIGHT.Health Condition 1: E663- Overweight
CTRI/2022/03/040968ATIONAL INSTITUTE OF AYURVEDA DEEMED TO BE UNIVERSITY JAIPUR
Completed
Phase 1
Study of Gairikadi Bidalaka and Chloramphenicol with Hydrocortisone Eye Ointment in BlepharitisHealth Condition 1: H010- Blepharitis
CTRI/2019/08/020678MAM Sumatibhai shah ayurved college60
Not yet recruiting
Phase 2
To study the effect of Kapalbhati and Raktashali Manda in the management of Obesity(Overweight person)Health Condition 1: E669- Obesity, unspecified
CTRI/2022/10/046668Vidarbha Ayurved Mahavidyalaya Amravati
Not yet recruiting
Phase 2
To assess the effectiveness ofSirovasti in two different time period with Ksheerabala taila in Non-Organic Insomnia.Health Condition 1: - Health Condition 2: F510- Insomnia not due to a substance orknown physiological condition
CTRI/2022/06/043073VPSV Ayurveda College Hospital Kottakal
Not yet recruiting
Phase 2
A clinical study to assess selected physiological, haematological and biochemical changes in the body during dhanyamla dhara in 2 methods in Rheumatoid arthritisHealth Condition 1: M069- Rheumatoid arthritis, unspecified
CTRI/2022/07/044264VPSV Ayurveda college Kottakkal